This AI Startup Just Raised $1.8M to Fix Psychiatry's Biggest Problem

Jan de Vries · 2026-08-19

Let's face it: psychiatrists are drowning. Not in paperwork, exactly, but in the sheer volume of information they need to process before they can even think about treating a patient. Aisel Health, a Copenhagen-based HealthTech company, just raised $1.8 million in a pre-Seed round to tackle that exact issue with an AI-powered operating system built specifically for psychiatric care. ### The Funding Round The round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside existing backers Rockstart and EIFO. That's a solid mix of new and old investors who clearly see something special in this young company. But here's what makes this interesting beyond the money: Aisel isn't trying to be another AI scribe that just transcribes conversations. They're building something more ambitious, and honestly, more necessary. ### The Real Problem in Psychiatry Here's a scenario that might sound familiar if you've ever worked in healthcare: a psychiatrist sits down to prepare for a patient appointment. Before they can even start assessing the patient's current state, they need to pull together history from referrals, previous notes, and multiple different systems. That's not a five-minute task. According to Aisel's research, "The Documentation Minute," psychiatrists spend far longer on this evidence-gathering than on actually writing the note itself. "Psychiatry doesn't need more generic technology bolted onto an already overburdened workflow," says Augusta Klingsten Peytz, co-founder and CEO. "It needs a product built around the realities of psychiatric care where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can." ### Why AI Scribes Aren't Enough The founders make a sharp point here. AI note-taking tools have exploded in popularity because they reduce burnout by writing notes faster. But faster notes create a different problem: when documentation becomes cheaper and quicker to produce, the information inside it becomes harder to find. "AI scribes work they write notes faster, and that's great for immediate burnout," says Christian Houen, co-founder and CPO. "But that's not what's keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it." That's the core insight driving Aisel's platform. Instead of just generating notes, the system turns interview recordings, existing documents, and the patient's own accounts into structured, contextual insights that surface exactly when the clinician needs them. Before, during, and after the consultation, Aisel provides direct access to all relevant documentation about the patient. ### Security and Compliance First Now, you might be thinking: "AI in healthcare? What about privacy?" Fair question. The company has been careful to address this head-on. They state that: - They do not have access to patients' medical records - Patient data is never used to train their AI models - All data is stored and processed on secure servers within Europe, in line with GDPR and local data protection regulations That last point matters, especially for a US audience watching European health tech developments. The strict regulatory environment in Europe isn't a barrier here; it's a feature that builds trust. ### What's Next for Aisel Founded in 2024 by Peytz and Houen, the company plans to use this funding to grow its clinical and engineering teams and fund its UK market entry. They've already got an active commercial pipeline in private psychiatry, and they're aiming for a Seed round after that. "Few problems in healthcare are as large or as overlooked as psychiatry's, and few founders are as passionate about solving it the way Augusta and Christian are," says Carolin Gabor, Managing Partner and GP at Caesar Ventures. It's hard to argue with that. Mental health care is stretched thin globally, and the administrative burden on clinicians is only getting worse. If Aisel can genuinely reduce that strain while improving patient care, this $1.8 million pre-Seed round might look like the start of something much bigger.